Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.07, 9.01 · 8-K

ImmuCell Corporation

ICCCNASDAQEQUITYCurrent

Submission of Matters to a Vote of Security Holders

ITEM 5.07. Submission of Matters to a Vote of Security Holders The 2026 Annual Meeting of Stockholders of the Company (the “2026 Annual Meeting”) was held by remote communication in the form of both a dial-in conference call and an audio webcast rather than an in-person event on Thursday, June 11, 2026, at 9:30 a.m. Eastern Time, for the following purposes:…

Filed Jun 17, 2026Accepted Jun 17, 2026, 2:19 PM EDTCIK 811641Accession 0001437749-26-020926
Share

Company context

ImmuCell Corporation’s (Nasdaq: ICCC) purpose is to create scientifically proven and practical products that improve the health and productivity of dairy and beef cattle. ImmuCell manufactures and markets First Defense®, which provides Immediate Immunity™ to newborn dairy and beef calves, and is developing Re-Tain®, a novel treatment for subclinical mastitis in dairy cows without FDA-required milk discard or pre-slaughter withdrawal label restrictions that provides an alternative to traditional mastitis antibiotics. Press releases and other information about the Company are available at: http://www.immucell.com.

Current securities

Recent company filings

  1. Results of Operations and Financial ConditionOct 13, 2026
  2. 10-Q filingAug 13, 2026
  3. Results of Operations and Financial ConditionAug 13, 2026
  4. Results of Operations and Financial ConditionJul 9, 2026
  5. Regulation FD DisclosureJun 10, 2026

Disclosure sections

Items 5.07, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.07Item 5.07 - Submission of Matters to Vote
ITEM 5.07. Submission of Matters to a Vote of Security Holders The 2026 Annual Meeting of Stockholders of the Company (the “2026 Annual Meeting”) was held by remote communication in the form of both a dial-in conference call and an audio webcast rather than an in-person event on Thursday, June 11, 2026, at 9:30 a.m. Eastern Time, for the following purposes: To elect to one-year terms as Directors of the Company the seven nominees listed in the 2026 Proxy Statement. To approve a non-binding advisory resolution on the Company’s executive compensation program. To approve the Company’s 2025 Stock Option and Incentive Plan. To approve an amendment to the Company’s Certificate of Incorporation to reflect certain Delaware law provisions regarding the exculpation of officers. To ratify the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2026. ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── At the 2026 Annual Meeting, there were present in person or by proxy 7,397,695 shares of the Company’s common stock, representing more than 81% of the total outstanding eligible votes. The final voting results for each proposal are as follows: To elect to one-year terms as Directors of the Company the nominees listed in the Company’s Proxy Statement dated April 24, 2026: ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── For Withheld Broker Non-Votes ────────────────────────────────────────────────────────────────────────────── Gloria J. Basse 5,177,979 9,815 2,209,901 P. Olivier te Boekhorst 5,180,197 7,597 2,209,901 Anthony A. Dimarco 5,179,503 8,291 2,209,901 Gilles Guillemette 5,166,860 20,934 2,209,901 David S. Tomsche 5,173,863 13,931 2,209,901 Kathy V. Turner 5,166,863 20,931 2,209,901 Paul R. Wainman 5,177,135 10,659 2,209,901 On the basis of this vote, each of the seven nominees was elected to a one-year term as a Director of the Company. To approve a non-binding advisory resolution on the Company’s executive compensation program: For Against Abstain Broker Non-votes ───────────────────────────────────────────────────────────── 4,793,553 29,155 365,086 2,209,901 92.4% of the shares voting at this meeting in person or by proxy voted in favor. On the basis of this vote, the non-binding advisory resolution on the Company’s executive compensation program was approved. To approve the Company’s 2025 Stock Option and Incentive Plan: For Against Abstain Broker Non-votes ───────────────────────────────────────────────────────────── 4,689,407 18,453 479,934 2,209,901 90.39% of the shares voting at this meeting in person or by proxy voted in favor. On the basis of this vote, the matter was approved. To approve an amendment to the Company’s Certificate of Incorporation to reflect certain Delaware law provisions regarding the exculpation of officers: For Against Abstain Broker Non-votes ───────────────────────────────────────────────────────────── 4,851,019 325,531 11,244 2,209,901 53.62% of total shares outstanding voted in favor. On the basis of this vote, the amendment to the Company’s Certificate of Incorporation to reflect certain Delaware law provisions regarding the exculpation of officers was approved. To ratify the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2026: ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── For Against Abstain Broker Non-votes ───────────────────────────────────────────────────────────── 7,344,196 14,645 38,854 0 99.28% of the shares voting at this meeting in person or by proxy voted in favor. On the basis of this vote, the Audit Committee’s selection of Wipfli LLP as the Independent Registered Public Accounting Firm of the Company for the year ending December 31, 2026 was ratified.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.